| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
USA. Buprenorphine Prescribing via Telehealth Delayed
USA. Buprenorphine Prescribing via Telehealth Delayed
Two federal agencies have delayed implementation of two rules that would have allowed clinicians to prescribe buprenorphine for opioid use disorder (OUD) for up to 6 months without an in-person visit, stating that more time is needed to review whether the rules are lawful.
The rules — “Expansion of Buprenorphine Treatment via Telemedicine Encounter” and “Continuity of Care via Telemedicine for Veterans Affairs Patients” — were initially proposed in March 2023, as reported by Medscape Medical News, and were revised after public input. (Medscape, USA, 28.03.2025)
https://www.medscape.com/viewarticle/buprenorphine-prescribing-telehealth-delayed-2025a10007hf